Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 6Tumor-Agnostic 4Genitourinary 4CNS 3Lymphoid 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Neoplasms 3Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

pembrolizumab 56Specimen Handling 28Biopsy 27Magnetic Resonance Spectroscopy 26Paclitaxel 22Blood Specimen Collection 21Nivolumab 20atezolizumab 18Standard of Care 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 17Oxaliplatin 13Fluorouracil 13Cisplatin 13Radiotherapy 12Radiosurgery 12Cyclophosphamide 12Pemetrexed 11Leucovorin 11Irinotecan 10Gemcitabine 10Docetaxel 10Capecitabine 10trastuzumab deruxtecan 8olaparib 8Taxes 8Ipilimumab 8durvalumab 7Trastuzumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hematologic Tests × Tumor-Agnostic × 1 year × Clear all
NCT07514715 2026-04-13

RT4

The Lymphoma Academic Research Organisation

Not yet recruiting
129 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT06999785 2026-04-06

OXYBAR

University Hospital, Angers

Phase NA Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT03409016 2025-09-05

Biomarkers of Immune-Related Toxicity

University of Colorado, Denver

Active not recruiting
69 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06979921 2025-08-14

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting
496 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡